Inner and outer retinal morphology were quantified in vivo for 6 nonglaucomatous and 10 glaucomatous optic neuropathy patients. Custom, ultrahigh-resolution imaging modalities were used to evaluate segmented retinal layer thickness in 3D volumes (Fourier-domain optical coherence tomography), cone photoreceptor density (adaptive optics fundus camera), and the length of inner and outer segments of cone photoreceptors (adaptive optics-optical coherence tomography). Quantitative comparisons were made with age-matched controls, or by comparing affected and nonaffected retinal areas defined by changes in visual fields. The integrity of outer retinal layers on optical coherence tomography B-scans and density of cone photoreceptors were correlated with visual field sensitivity at corresponding retinal locations following reductions in inner retinal thickness. The photoreceptor outer segments were shorter and exhibited greater variability in retinal areas associated with visual field losses compared with normal or less affected areas of the same patient's visual field. These results demonstrate that nonglaucomatous and glaucomatous optic neuropathies are associated with outer retinal changes following long-term inner retinal pathology.
Introduction
The optic neuropathies are a diverse group of diseases that have a wide range of origins, including heredity, trauma and compression, ischemia, metabolic or toxic disturbances, and unknown etiologies. 1 Nevertheless, the optic neuropathies have a common manifestation: damage to the retinal ganglion cells, [2] [3] [4] [5] [6] usually beginning with axonal degeneration or demyelination followed by retrograde degeneration to the cell body and anterograde degeneration to central projection sites. Clinical diagnosis is based on ophthalmoscopically visible abnormalities of the optic disk color and shape, with accompanying changes in the retinal vasculature and retinal nerve fiber layer. Quantification of nerve fiber layer integrity by optical coherence tomography (OCT) 7, 8 or scanning laser polarimetry, and visual field changes 9, 10 are often important in differential diagnosis of these disorders.
Additional visual symptoms in various types of optic neuropathy include loss of visual acuity, impaired contrast sensitivity, 11, 12 and decreased color discrimination. 13, 14 In acquired deficiencies of color, Kö llner's rule 15 posits that red-green color defects are more often associated with optic nerve and central diseases, whereas tritan defects are more often associated with changes in the outer retina. Yet, patients with optic neuritis have mixed color vision changes 16 and patients with glaucoma often show yellow-blue changes. 17, 18 This would suggest that outer retinal changes may accompany optic neuropathies, but an alternative explanation might be that there is selective loss in ganglion cells carrying signals from the short-wave sensitive cones. 19 The electroretinogram a-wave and multifocal responses are dominated by photoreceptors and bipolar cell signals, and studies of optic neuropathy patients provide further evidence that outer retinal changes may sometimes, 20, 21 but not invariably, 22, 23 occur. Anatomical changes would seemingly settle the issue as to whether there are upstream changes in optic neuropathies, but these results are also equivocal. Swelling and loss of photoreceptors have been reported in human and monkey model 24, 25 in conjunction with retinal ganglion cell damage. This is not, however, supported by other studies 26, 27 in which the outer retina of glaucoma patients was examined histologically.
Here, we review results obtained from our laboratory from carefully classified patients having nonglaucomatous or glaucomatous optic neuropathies. In vivo imaging was carried out with three research-grade high-resolution instruments [28] [29] [30] that permitted quantification of inner and outer retinal morphology and correlation with visual fields. The results demonstrate both inner and outer retinal changes in both nonglaucomatous and glaucomatous optic neuropathies when there were stable and long-standing losses in visual fields.
Subjects and methods

Subjects
Six patients, age 34-67 years, with nonglaucomatous optic neuropathy were tested: three with multiple sclerosis (MS), one with bilateral nonarteritic anterior ischemic optic neuropathy (NAION), one with bilateral optic nerve head drusen and NAION, and one with idiopathic intracranial hypertension (IIH; pseudotumor cerebri). Ten patients with glaucoma were also included: one with pigmentary dispersion glaucoma, seven with primary open-angle glaucoma, and two with normal tension glaucoma. Seven normal subjects (21-58 years old) were recruited for direct comparisons of various aspects of retinal morphology.
All participants were screened with comprehensive clinical examinations. Patients were additionally examined by a neuro-ophthalmologist and/or glaucoma specialist. Screening included direct and indirect ophthalmoscopy, visual field analysis, and Stratus (Zeiss Meditec, Dublin, CA, USA) OCT imaging. All glaucoma patients had enlarged cup-to-disc ratios with thinning of neural rims. Most exhibited additional changes such as disk hemorrhages, peripapillary atrophy, focal notching, and visual field defects. Refractive error was an exlusionary criterion only if it exceeded ±3D spherical and ±3D cylinder.
Procedure
Written informed consent was obtained from each participant after explaining the procedures and before any experimental measurements. The Tenets of the Declaration of Helsinki were observed throughout, and the protocol was approved by the Institutional Review Board of the University of California, Davis, School of Medicine.
Three laboratory instruments were used for ultrahighresolution imaging. Each instrument included a calibrated fixation target so that images from the different modalities could be registered. Subject alignment was maintained by the use of a dental-impression bite-bar and forehead rest. Before image acquisition, eye drops were used to induce cycloplegia and pupil dilation.
In addition to vision science goals, our laboratory has engineering goals for improvement of image acquisition and post-processing. In achieving the latter objectives, some instruments were modified over the course of our studies. However, our instruments had sufficient resolution at all times for the imaging described in this paper. Here, we describe briefly recent versions of these instruments.
Fourier-domain optical coherence tomography
This instrument is a fiber-based Michelson interferometer permitting acquisition of cross-sectional retinal images (B-scans; 181 field of view) that can be registered to form volumes for layer segmentation. 31 An example from a normal 34-year-old observer is shown in Figure 1 . Our instrument is similar to commercial Fourier-domain optical coherence tomography systems, but has higher theoretical axial resolution (3.6 mm) owing to a broader bandwidth light source, a superluminescent diode (Superlum, Carrigtwohill, Co. Cork, Ireland) with an 852 nm central wavelength and 79 nm FWHM. The beam power incident on the cornea is 450 mW. The theoretical lateral resolution is 10 mm. This system uses one of two line detectors: CCD (Atmel, San Jose, CA, USA) for standard speed acquisition (up to 24 frames/s with 1000 A-scans) and CMOS (Basler, Ahrensburg, Germany) for high-speed acquisition (up to 125 frames/s with 1000 A-scans). Other details are published elsewhere. 32 Adaptive optics fundus camera (AO-FC) This instrument is designed to provide en face images with high lateral resolution for imaging the cone photoreceptor mosaic. It does so by measuring the observer's wavefront aberrations and then correcting the higher-order aberrations in a closed-loop system. 33 Lower-order aberrations, sphere and cylinder, are corrected with trial lenses in the spectacle plane. Briefly, the pupil is imaged onto a Shack-Hartmann wavefront sensor with a 20 Â 20 lenslet array across a 6 mm pupil.
A superluminescent diode operating at 835±20 nm is used to form a reference spot on the retina for wavefront sensing. High-order aberrations are corrected with a 68 mm, 109 actuator, continuous surface deformable mirror (DM; Litton ITEK, Lexington, MA, USA) that has an approximate mirror stroke of ± 2 mm. Direct slope control is used for the individual DM actuators. The wavefront is sampled at 20 Hz, yielding a closed-loop bandwidth of B0.9 Hz and a gain of 30%. After minimizing wavefront error, an imaging source (300 W xenon lamp), shaped spectrally by an interference filter (550 or 650 ± 40 nm), is passed to the retina and backreflected following the corrected path of the DM and is re-imaged onto a cooled CCD camera (VersArray XP; Princeton Instruments, Monmouth, NJ, USA). The exposure duration is 10 ms with 0.25 mJ of light delivered through a 2.4 mm diameter entrance pupil. The imaging camera is translated axially on a motorized stage to correct for the ocular longitudinal chromatic aberration between the wavefront sensor beacon at 835 nm and the visible wavelengths used for imaging. The resultant images have a field of view of 11 with 2.5 mm lateral resolution, sufficient to image cone photoreceptors outside the foveola. Custom software permits semi-automatic cone counting, 34 as illustrated in Figure 2 . Cone densities were corrected for the presence of blood vessels in the image.
Adaptive optics-optical coherence tomography (AO-OCT)
The purpose of this instrument is to produce 3D isotropic ultrahigh-resolution retinal images. This is possible because axial and lateral resolution are largely independent in AO-OCT such that the major advantages of each modality can be realized. [35] [36] [37] One limitation in this approach is that when the bandwidth of the OCT imaging beam increases to achieve maximal axial resolution, there may be a loss in lateral resolution due to the longitudinal chromatic aberration of the eye. This can be compensated to a large extent by use of a custom achromatizing lens, which we place in the sample arm. 37 In our system, the light source used for both OCT and wavefront sensing is a superluminescent diode (Superlum BroadLighter, Superlum) having a central wavelength of 836 nm and bandwidth of 112 nm. The light level at the entrance pupil of the subject's eye does not exceed 400 mW. The AO arm of this system cascades two wavefront correctors, a large stroke 37-actuator bimorph DM (AOptix, Campbell, CA, USA), and a microelectromechanical system (MEMS) 140-actuator DM (Boston Micromachines, Cambridge, MA, USA). The highstroke DM permits imaging without trial lenses, which would otherwise cause a dispersion difference between the reference and sample arms. The two DMs are not operated simultaneously; rather, the optimized correction with the AOptix DM is fixed after the wavefront error is minimized, and then the MEMS DM is operated to improve aberration correction by operating in a closed loop at a rate of 16 Hz. By use of two DMs it is also possible to shift the focus so that maximal resolution occurs for layers of interest, as illustrated by Figure 3 . With diffraction-limited correction, the resolution is B3.0 mm in all three directions over a field of view of 31 Â 31.
Results
Maps of inner retina in optic neuropathies
Although the image presented in Figure 1 from a normal observer shows a well-delineated retinal nerve fiber layer that is easily segmented from the 3D volume, it is often not as well defined in individuals with optic neuropathies. In those cases, segmentation is more reliable if a combined three-layer inner retinal complex (retinal nerve fiber layer, ganglion cell layer, and inner plexiform layer) is segmented. From the extracted retinal layers, an en face thickness map may be constructed.
As expected from previous work, 38,39 the thickness of the inner retinal complex is reduced in individuals who have a loss in visual field sensitivity. For example, Figure 4 shows a normal 35-year-old subject and an MS patient, age 43 years, having a borderline normal field with some scattered missed spots in the periphery. Their inner retinal thickness maps were similar, with the thickness ranging between 50 and 110 mm. In contrast, optic neuropathy patients with stable visual field losses showed a reduction in inner retinal thickness. Figure 4 (lower two panels) shows visual field and inner retinal thickness maps for patients with IIH (age 47) and optic nerve head drusen with NAION (age 54). Visual fields were measured with the HVF SITA 24-2 algorithm, size III stimulus. Both the IIH and NAION patients showed marked constriction of visual fields with macular sparing. In both cases, the thickness of the inner retinal complex ranged from B0-50 mm to 75 mm for small patches in the IIH patient. The thickness distribution was correlated with visual fields, showing reduced thickness at the locations where visual sensitivity is reduced, and increased thickness over areas with higher visual sensitivity.
All nonglaucomatous and glaucomatous optic neuropathy patients showed reductions in the thickness of the three-layer complex, provided they had long-term losses in visual field sensitivity. To examine whether there may also be changes in outer retinae of these patients, visual field maps were used to guide the choice of locations for ultrahigh-resolution imaging.
Outer retinal changes in nonglaucomatous optic neuropathies
Outer retinal morphology was examined by Fourierdomain optical coherence tomography and AO-OCT to determine the integrity of the three layers anterior to the RPE, the external limiting membrane (ELM), connecting cilia (between inner (IS) and outer segments (OS)), and Verhoeff's membrane, where the cone outer segment tips are enveloped by microvilli from the RPE. In addition, the AO-FC was used to acquire en face images of cone photoreceptor mosaics. Population statistics to evaluate losses in cone density are limited; however, outside the fovea, cone counts that we 34 and others 40 obtain from normal retinae in vivo agree well with histological counts 41 reported for normal retina. Therefore, we use the latter as a reference and specify densities obtained from patient AO-FC images in terms of percentages of what is expected from normal histology. Here, we present results from two patients having nonglaucomatous optic neuropathy.
Photoreceptor mosaics from the left eye of a 47-year-old female with IIH, or pseudotumor cerebri, are shown in Figure 5 . This patient had bilateral optic nerve pallor as seen in her fundus photos; the thickness map of her inner retina is presented in Figure 4 along with the gray scale visual field map from the SITA Standard 24-2 HVF. In this figure, we see the total deviation map, which was predictive of regions of corresponding reduction in cone density, which varied left to right in the figure from 8028 per mm 2 at 21 nasal, 71 inferior, 16 169 per mm 2 at 41 nasal, 41 inferior retina, to 10 306 at 41 temporal, 41 inferior. These cone densities are 35, 93, and 59%, respectively, of normal values. Thus, in addition to expected inner retinal pathology, there is also outer retinal abnormality in this patient.
A second nonglaucomatous optic neuropathy patient was a 54-year-old male with optic nerve drusen. He was a smoker who, at age 19, woke up with painless vision loss following dehydration from hiking at high altitude. He sustained severe constriction of visual fields, but preserved central vision (VA ¼ 20/15). Figure 4 (bottom) shows his severe loss of visual field and inner retina. He had been extensively tested for many years and was, therefore, described in a separate case study. 29 It is presumed that he had NAION, but this was not verifiable given the long lapse between his acute vision loss and first examination. Figure 6 presents his total deviation map from a 10-2 visual field and en face images of his cone mosaic at two retinal locations, corresponding to regions of normal and abnormal visual field sensitivity. In the normal region of inferior visual field (corresponding to 21 superior retina), his cone density was 21 885 cones/mm 2 which is 89% of the cone density expected. In contrast, in an area of severe vision loss and inner retinal changes (81 temporal, 81 inferior retina), he has only 5594 cones/mm 2 , which is 57% of what is expected from normal retina. The other eye of this patient showed similar cone densities for areas of the visual field that had comparable visual field sensitivity losses.
As can be seen in Figure 1 , three well-defined contours anterior to the RPE may be identified in normal outer retina. The top layer represents the ELM, the second layer is at the junctions between the IS and OS of cone photoreceptors (IS/OS), and the third layer is Verhoeff's membrane. With AO-OCT, gaps in the layers are ascribable to gaps between adjacent cones (see Figure 3 left). Note that in our patient shown in Figure 6 , the area with a more intact cone mosaic (21 superior retina) in AO-FC images, there are three distinct contours in the outer retina, whereas in the area with an abnormal cone mosaic (81 temporal, 81 inferior retina), Verhoeff's membrane is not visible. This observation is consistent with cone losses due to dystrophy of the outer segments.
Among the other nonglaucomatous optic neuropathy patients, there were three MS patients tested. It is noteworthy that one showed a normal cone mosaic, whereas another showed a more abnormal cone mosaic than expected from data of other optic neuropathy patients. The MS patient with a normal cone mosaic was a 34-year-old female with fluctuating visual field defects and mild optic disk pallor in both eyes. The AO-FC images showed normal cone densities in the four regions of retina tested. Eight months later, she had normal visual fields, consistent with the conclusion that upstream retinal changes occur only after sustained loss of visual fields. More severe visual field defects of a longstanding nature were documented for a 45-year-old female MS patient with bilateral optic atrophy combined with systemic lupus erythematosus and arthritis. This individual had cone densities that were only 3-27% of expected normal values in the right eye and 27-52% in the left eye. These cone losses were greater than those associated with comparable visual field losses in other patients. It is not clear why this occurred, but it may be related to her serious systemic, as well as neuro-ophthalmological, conditions. To further examine these losses in cone density, we considered that perhaps more cones were present but not visible because of changes in their directional sensitivity. This was tested by measuring the optical Stiles-Crawford effect, 42 in which the imaging light for the AO fundus camera was varied in 1 mm increments along the horizontal axis of the entrance pupil. If there is a systematic change in angular tuning of the photoreceptors that caused a change in cone visibility, it is expected that changing the entrance pupil would reveal them as normal retina, which is characterized by little disarray over the imaging apertures of our methods. For this MS patient, the Stiles-Crawford effect was examined over a patch of retina at 41 temporal, 41 superior in the right eye. With different entrance pupils, some cones were revealed that were not previously visible, while others that were previously visible were no longer visible. The net effect is that misidentification of cones due to possible disruptions of their waveguide properties would only affect cone counts by a few percent in this patient. Combining all the cones at the various entrance pupil positions still results in cone density substantially below that expected in a healthy eye.
Outer retinal changes in glaucomatous optic neuropathies
The analysis of images with glaucomatous optic neuropathies was similar to those described above, but in addition, AO-OCT images were used to measure the length of IS and OS of cone photoreceptors. IS length was defined as the distance between the ELM and the IS/OS junction of a single cell ('dot') positioned directly underneath the ELM. OS length refers to the distance between two 'dots' that can be vertically paired at the junctions of IS/OS and OS/RPE representing a single cone photoreceptor. In most cases, areas of normal and abnormal visual sensitivity were used to select locations that were equidistant from the foveola. Figure 7 shows the enlarged cup and notch of the optic disk in the fundus image of a 25-year-old male with pigmentary dispersion glaucoma. His visual field is characterized by a superior arcuate defect and an inferior partial arcuate defect. Note that one of the regions of visual field chosen is depicted as abnormal in the total deviation plot, but is relatively normal (28 dB) compared with the other areas. Three areas of retina corresponding to different visual field sensitivities are shown. Cone densities from left to right were 5890, 24 400, and 5556 cones/mm 2 , representing 23, 100, and 35%, respectively, of the expected normal values for these retinal loci. The AO-OCT images show that only the area with 100% of normal cone density is associated with three discrete outer retinal layers. As shown by the values listed below the AO-OCT B-scans, the cone IS lengths were similar at all retinal locations. However, there was a significant difference in OS lengths among the three areas, with the areas of reduced cone density having lower mean lengths and higher variability.
The results for the right eye of a primary open-angle glaucoma patient (age 63 years) are presented in Figure 8 . The HVF 24-2 shows a mild superior arcuate defect. En face images from areas of high-and low-visual sensitivity show cone densities varying from 29% (4.51 temporal, 4.51 inferior retina) to 100% (4.51 temporal, 4.51 superior retina) of expected cone density. The three layers in the outer retina are more clearly demarcated above the RPE in the area of higher visual sensitivity. Whereas the IS lengths do not vary for the two locations, the OS are shorter and more variable in the retinal area with lower sensitivity and lower cone density.
All glaucoma patients tested showed a similar pattern of results to those shown in Figures 7 and 8 . Areas of reduced visual field sensitivity were not different from normal areas in their IS lengths, whereas the OS lengths were shorter and more variable in retinal areas associated with sensitivity loss. These results support the conclusion that the reduced cone densities revealed in en face images are due to reduction in the OS lengths. These same areas show a disruption in visibility of Verhoeff's membrane.
Conclusions
Despite the diverse etiologies of optic neuropathies, upstream losses in the outer retina have been identified in all cases manifesting long-term visual field loss and following thinning of the three-layer inner retinal complex. Structural changes in outer retina are thought to lag visual field changes and losses in inner retina so that the quantitative relations between inner and outer retinal changes are likely to depend on the state of disease progression, and this may also vary with the particular type of optic neuropathy. Nevertheless, in areas of sustained visual field abnormality, we consistently observed that cone photoreceptors were less reflective, resulting in dark regions in the en face images, and there was disruption of outer retinal layers in corresponding areas revealed by high-resolution OCT and AO-OCT images. In cases of transient visual field impairment and normal inner retina, there were no detectable upstream abnormalities in outer retina. The cones were densely packed and the integrity of the outer retina was implied by intact Verhoeff's membrane.
The data presented here are buttressed by related studies, which together 24, 25, 43 demonstrate that outer retina is vulnerable in nonglaucomatous and glaucomatous optic neuropathies. It would be surprising if prolonged visual field loss were accompanied by changes restricted to the nerve fiber layer and ganglion cells without affecting other retinal layers including photoreceptors. All of the patients we tested exhibited a strong association between structural changes in cone photoreceptors and loss of visual sensitivity as well as thinning of the three-layer inner retinal complex. It will be important to understand the remodeling that takes place in all parts of retina associated with optic neuropathies to effect better monitoring, interventions and therapies for these severely blinding diseases.
